BrainChild Bio: Funding, Investors & Team (Nov 2026)
BrainChild Bio is a biotechnology company in the clinical stage that specializes in pediatric brain tumors. They use CAR-T cell technology to create treatments for tumors in the central nervous system, particularly focusing on DIPG. Their research is based on previous studies at Seattle Children's Hospital and their goal is to offer new treatments for incurable brain cancers in children.
BrainChild Bio has raised $116M across 2 funding rounds on record, the most recent a Series A of $116M announced in Sep 2026.
That round is above the $8.9M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
BrainChild Bio Company Profile and Key Stats
Latest funding round on record: Sep 2026.
BrainChild Bio Funding Rounds
BrainChild Bio raised $300k in an undisclosed round announced in Jan 2025.
1.7 years later, a Series A of $116M was announced in Sep 2026.
BrainChild Bio Investors
BrainChild Bio Founders and Leadership Team
Contact details for the BrainChild Bio team: 3 of 3 have an email address on file, 2 have a LinkedIn profile.
Start 14-day free trial →BrainChild Bio Funding Compared to Other Biotechnology Startups
BrainChild Bio's latest round of $116M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like BrainChild Bio in Biotechnology and Seattle
Companies Similar to BrainChild Bio
Araceli Biosciences specializes in creating scientific instruments for discovering tissue- and cell-based…
Switchpoint Bio is a biotechnology company that offers immune relevant drug treatments.
Nanopath Inc. is a company that specializes in molecular diagnostics and allows for fast, high-quality…
Frontier Bio is creating lab-grown human tissues as an ethical replacement for animal studies and is setting…
Delix Therapeutics is a neuroscience company focused on harnessing the power of psychoplastogens—novel…
Rgenta Therapeutics develops a pipeline of oral, small-molecule RNA-targeting medicines with an initial focus…
Zafrens, a pharmaceutical research organization, focuses on designing life sciences solutions for…
Quanta is a biotechnology company uncovering novel cancer therapeutic candidates to target driver oncogenes.…
Arctic Therapeutics specializes in finding the genetic origins of common diseases and creating successful…
100XBIO is creating a cutting-edge platform for analyzing multiple T-cells automatically, aiming to…
MEND is a company focused on life sciences, determined to assist individuals in achieving better health…
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
BrainChild Bio Funding FAQs
What does BrainChild Bio do?
BrainChild Bio is a biotechnology company in the clinical stage that specializes in pediatric brain tumors. They use CAR-T cell technology to create treatments for tumors in the central nervous system, particularly focusing on DIPG. Their research is based on previous studies at Seattle Children's Hospital and their goal is to offer new treatments for incurable brain cancers in children.
How much funding has BrainChild Bio raised?
BrainChild Bio has raised $116M across 2 rounds on record. The most recent is a Series A of $116M announced in Sep 2026.
When did BrainChild Bio last raise funding?
BrainChild Bio's most recent funding round on record is a Series A of $116M, announced in Sep 2026.
Who has invested in BrainChild Bio?
Investors on record for BrainChild Bio include WRF Capital, Seattle Children’s, ScaleReady.
Who founded BrainChild Bio?
FundedIQ lists Michael Jensen (Founder) at BrainChild Bio.
Where is BrainChild Bio headquartered?
BrainChild Bio is based in Seattle, Washington, United States.
How many employees does BrainChild Bio have?
BrainChild Bio is in the 11-50 employee band.
When was BrainChild Bio founded?
BrainChild Bio was founded in 2023.
How does BrainChild Bio's funding compare to other Biotechnology startups?
BrainChild Bio's latest round of $116M is above the $8.9M median round size for Biotechnology companies on FundedIQ across 4,188 tracked companies over the last two years.
About FundedIQ's BrainChild Bio Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for BrainChild Bio is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.